ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 154 filers reported holding ACHILLION PHARMACEUTICALS IN in Q1 2016. The put-call ratio across all filers is 0.20 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2018 | $48,000 | -23.8% | 12,985 | -41.8% | 0.00% | – |
Q2 2018 | $63,000 | -30.0% | 22,330 | -7.9% | 0.00% | -100.0% |
Q1 2018 | $90,000 | -17.4% | 24,234 | -35.9% | 0.00% | 0.0% |
Q4 2017 | $109,000 | +14.7% | 37,796 | +220.7% | 0.00% | 0.0% |
Q3 2016 | $95,000 | -19.5% | 11,786 | -22.3% | 0.00% | 0.0% |
Q2 2016 | $118,000 | +13.5% | 15,173 | +13.0% | 0.00% | 0.0% |
Q1 2016 | $104,000 | -3.7% | 13,424 | +34.6% | 0.00% | 0.0% |
Q4 2015 | $108,000 | +27.1% | 9,972 | -18.6% | 0.00% | 0.0% |
Q3 2015 | $85,000 | +157.6% | 12,255 | +229.5% | 0.00% | – |
Q2 2015 | $33,000 | +13.8% | 3,719 | +28.6% | 0.00% | – |
Q1 2015 | $29,000 | +16.0% | 2,891 | +42.8% | 0.00% | – |
Q4 2014 | $25,000 | +4.2% | 2,025 | -16.8% | 0.00% | – |
Q3 2014 | $24,000 | +26.3% | 2,434 | -2.5% | 0.00% | – |
Q2 2014 | $19,000 | +111.1% | 2,497 | -8.9% | 0.00% | – |
Q1 2014 | $9,000 | 0.0% | 2,740 | +1.3% | 0.00% | – |
Q4 2013 | $9,000 | -67.9% | 2,705 | -70.6% | 0.00% | – |
Q3 2013 | $28,000 | -30.0% | 9,199 | +90.3% | 0.00% | – |
Q2 2013 | $40,000 | – | 4,834 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
IFP Advisors, Inc | 0 | $0 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |